R) multiple myeloma (M…

Overview of attention for article published in Journal of Clinical Oncology, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 14,151 followers.

RT @szusmani: In BCMA exposed/refractory MM, Elranatamab SC shows a response rate ~60%, CRS ~59% (grade 1/2), ICANS in 3.6% (grade 1/2), me…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.